This is the authors' abstract. We don't add key points for this paper.
Molecular radiotherapy is a treatment modality that requires personalized dosimetry for efficient treatment and reduced toxicity. Current clinical imaging systems and miniaturized gamma-cameras lack the necessary features for this task. In this paper, we present the design and optimization of a mobile gamma-camera with a 10×10 cm field of view tailored for quantitative imaging during 131I therapy of thyroid diseases. The camera uses a monolithic 10×10×1 cm CeBr3 scintillator coupled to a 16×16 SiPMs array and commercial electronics. It exhibits high imaging performance with an intrinsic spatial resolution of 1.15 mm FWHM, an energy resolution of 8% FWHM at 356 keV and negligible deadtime up to 150 kcps. Images are reconstructed in real time using a convolutional neural network. The manufacturing method of tungsten collimators and shielding was optimized using laser 3D printing to achieve an effective density of 97% that of bulk tungsten. Their geometry was adjusted with Monte-Carlo simulations in order to reduce septal penetration and scattering and optimize the signal-to-noise ratio at short times after treatment administration. Two high-energy parallel-hole collimators with high sensitivity or very high spatial resolution were designed for treatment planning and post-treatment control. The fully operational gamma-camera will soon be clinically assessed.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bossis et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: